Clinical Study on the Therapeutic Efficacy of Biportal Endoscopic Decompression Spine Surgery and Lumbar Decompression Fusion Surgery in the Treatment of Degenerative Lumbar Spondylolisthesis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-90
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine

About this trial

This study aims to systematically evaluate the therapeutic efficacy of dual-channel endoscopic spinal decompression versus lumbar decompression with fusion for degenerative lumbar spondylolisthesis. Patients undergoing either procedure will undergo detailed preoperative and postoperative follow-up to compare outcomes between the two techniques, specifically assessing postoperative pain relief, neurological improvement, and the incidence of surgical complications.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged between 50 and 90 years old with a confirmed diagnosis of degenerative lumbar spondylolisthesis;

Clinical symptoms include chronic pain, nerve compression, or motor dysfunction, confirmed by imaging studies (e.g., MRI or CT);

No significant improvement after at least 3 months of conservative treatment (e.g., medication, physical therapy), meeting surgical indications;

Understand and consent to the relevant procedures of this study, and sign the informed consent form.

Disqualifiers

Patients exhibiting acute spinal cord compression symptoms or requiring urgent surgical intervention;

Patients with a history of spinal surgery or conditions such as spinal deformities, severe osteoporosis, or active infections that may compromise surgical outcomes;

Patients with severe comorbidities affecting assessment, such as cardiovascular disease, liver or kidney failure, or uncontrolled diabetes;

Patients with psychiatric disorders or cognitive impairments preventing understanding or cooperation with the study process;

Trial population

Patients with lumbar degenerative spondylolisthesis

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 2 trial groups
Group A: UBE
Group B: Fusion

Trial outcomes

Primary outcomes

1

VAS

Pain Score

Time frame
36 month
2

JOA score

Function Score

Time frame
36month
3

ODI

Function Score

Time frame
36month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.